Novo Nordisk A/S made an unsolicited bid for US biotech firm Metsera Inc., sparking a heated battle with Pfizer Inc. to get their hands on weight-loss treatments that both drugmakers want in order to regain lost ground in the booming market.
A flurry of big deals in sectors ranging from mining to storage has provided respite for the world’s dealmakers after their slowest start to a year in two decades.
